Trupanion (NASDAQ:TRUP) Announces Earnings Results, Misses Expectations By $0.02 EPS

Trupanion (NASDAQ:TRUP - Get Free Report) posted its quarterly earnings results on Wednesday. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02), Zacks reports. Trupanion had a negative return on equity of 3.11% and a negative net margin of 0.75%. The firm had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million.

Trupanion Stock Performance

Shares of TRUP traded down $2.45 during trading hours on Friday, hitting $32.95. The company had a trading volume of 1,785,171 shares, compared to its average volume of 630,090. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The business has a fifty day moving average of $48.04 and a 200-day moving average of $47.89. Trupanion has a 12 month low of $19.69 and a 12 month high of $57.90. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of -143.26, a PEG ratio of 8.29 and a beta of 1.60.

Insider Activity at Trupanion

In related news, CFO Fawwad Qureshi sold 9,867 shares of the company's stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $53.08, for a total value of $523,740.36. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Emily Dreyer sold 900 shares of the company's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $54.55, for a total transaction of $49,095.00. Following the completion of the transaction, the senior vice president now owns 23,808 shares in the company, valued at $1,298,726.40. This trade represents a 3.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,581 shares of company stock worth $615,159. Corporate insiders own 5.50% of the company's stock.

Analyst Upgrades and Downgrades

TRUP has been the topic of several analyst reports. Stifel Nicolaus dropped their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research report on Thursday. Northland Securities increased their price objective on shares of Trupanion from $45.00 to $50.00 and gave the company a "market perform" rating in a research report on Thursday, October 31st. Finally, Piper Sandler dropped their price objective on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $46.60.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.